全文获取类型
收费全文 | 2034篇 |
免费 | 99篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 57篇 |
妇产科学 | 63篇 |
基础医学 | 200篇 |
口腔科学 | 115篇 |
临床医学 | 126篇 |
内科学 | 383篇 |
皮肤病学 | 218篇 |
神经病学 | 90篇 |
特种医学 | 105篇 |
外科学 | 385篇 |
综合类 | 28篇 |
一般理论 | 1篇 |
预防医学 | 45篇 |
眼科学 | 66篇 |
药学 | 128篇 |
中国医学 | 6篇 |
肿瘤学 | 83篇 |
出版年
2023年 | 17篇 |
2022年 | 21篇 |
2021年 | 50篇 |
2020年 | 37篇 |
2019年 | 35篇 |
2018年 | 51篇 |
2017年 | 43篇 |
2016年 | 56篇 |
2015年 | 67篇 |
2014年 | 86篇 |
2013年 | 87篇 |
2012年 | 102篇 |
2011年 | 113篇 |
2010年 | 80篇 |
2009年 | 75篇 |
2008年 | 91篇 |
2007年 | 117篇 |
2006年 | 96篇 |
2005年 | 106篇 |
2004年 | 98篇 |
2003年 | 73篇 |
2002年 | 87篇 |
2001年 | 60篇 |
2000年 | 40篇 |
1999年 | 28篇 |
1998年 | 19篇 |
1997年 | 14篇 |
1996年 | 13篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1992年 | 19篇 |
1991年 | 15篇 |
1990年 | 19篇 |
1989年 | 23篇 |
1988年 | 19篇 |
1987年 | 19篇 |
1986年 | 21篇 |
1985年 | 27篇 |
1984年 | 18篇 |
1983年 | 16篇 |
1982年 | 15篇 |
1981年 | 9篇 |
1979年 | 20篇 |
1978年 | 11篇 |
1977年 | 10篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1973年 | 12篇 |
1972年 | 12篇 |
1967年 | 10篇 |
排序方式: 共有2141条查询结果,搜索用时 312 毫秒
21.
22.
Cancer is a major worldwide health problem and one of the leading causes of death either in developed or developing countries. Plant extracts and derivatives have always been used for various disease treatments and many anticancer agents issued from plants and vegetables are clinically recognized and used all over the world. Lycium europaeum (Solanaceae) also called “wolfberry” was known since ancient times in the Mediterranean area as a medicinal plant and used in several traditional remedies. The Lycium species capacity of reducing the incidence of cancer and also of halting or reserving the growth of cancer was reported by traditional healers. In this study, the antiproliferative capacity, protective properties, and antioxidant activity of the hydro-alcoholic fruit extract of Lycium europaeum were investigated. Results showed that Lycium extract exhibits the ability to reduce cancer cell viability, inhibits proliferation, and induces apoptosis in A549 human lung cancer cells and PC12 rat adrenal medulla cancer cells, in a concentration- and time-dependent manner. Cytotoxic effect on normal rat cerebellum granule cells was assessed to be nonsignificant. Results also showed that Lycium fruit extract protected lipids, proteins, and DNA against oxidative stress damages induced by H2O2 via scavenging reactive oxygen species. 相似文献
23.
24.
25.
26.
27.
Ramazan Kargin M.D. Feyza Kargin M.D. Halil Mutlu M.D. Yunus Emiroglu M.D. Selcuk Pala M.D. Mustafa Akcakoyun M.D. Soe Moe Aung M.D. Reha Baran M.D. Nihal Ozdemir M.D. 《Echocardiography (Mount Kisco, N.Y.)》2011,28(1):52-61
Background: Previous studies have demonstrated an increased risk for cardiovascular events and pulmonary disease in patients with biomass fuel exposure (BFE). However, biventricular heart function has yet to be investigated in these patients. Left ventricular (LV) myocardial performance index (LVMPI), which is an index of global ventricular function, incorporates ejection, isovolumic relaxation, and contraction times. In this study, pulmonary function and biventricular heart function were investigated in nonsmoking female patients with BFE. Methods: Our study population consisted of 46 female patients with BFE (group 1) and 31 control subjects (group 2). Pulmonary function tests and transthoracic echocardiographic examination were performed. Right ventricular myocardial performance index (RVMPI) and LVMPI were obtained by tissue Doppler imaging echocardiography (TDI). Results: BFE caused obstructive and restrictive spirometric impairments. RVMPI was higher in group 1 (0.55 ± 0.07) than group 2 (0.46 ± 0.06) (P = 0.042) and LVMPI was higher in group 1 (0.54 ± 0.08) than group 2 (0.47 ± 0.05) (P = 0.032). Also, pulmonary artery systolic pressure was higher in group 1 than group 2 (P = 0.02). Conclusions: BFE causes both obstructive and/or restrictive lung disease and systolic and diastolic biventricular dysfunction. Nonetheless, long‐term studies are needed to understand on BFE‐related ventricular dysfunctions and to document subsequent cardiovascular events. (Echocardiography 2011;28:52‐61) 相似文献
28.
29.
Abstract: Dyskeratosis congenita (DKC) is an inherited disorder that usually presents in males, consisting of the triad of leukoplakia of the mucous membranes, nails dystrophy and skin pigmentation. Oral and dental abnormalities may also be present. Most cases are X-linked autosomal dominant, but recessive forms have also been reported. This study describes herein a case in which the classic triad of signs was present, along with the development of leukoplakia in the buccal mucosa. Our patient, a 25-year-old man, presented with several characteristic systemic features of this condition, together with the following oral features: hypodontia, delayed dental eruption, short blunt roots, extensive caries, gingival inflammation and bleeding, loss of alveolar bone and buccal mucosa with leukoplakia and irregular ulcers. The patient was given full preventive care. The primary teeth were extracted under local anaesthesia. After establishing optimal oral health, oral hygiene instructions were given to the patient and he was rehabilitated with fixed and removable partial denture. Prosthetic treatments were carried out after establishing optimal oral health. This treatment option appears beneficial in this patient, resulting in rehabilitation of occlusion and less mechanical irritation to the oral mucosa. 相似文献
30.
Giugliano RP Roe MT Harrington RA Gibson CM Zeymer U Van de Werf F Baran KW Hobbach HP Woodlief LH Hannan KL Greenberg S Miller J Kitt MM Strony J McCabe CH Braunwald E Califf RM;INTEGRITI Investigators 《Journal of the American College of Cardiology》2003,41(8):1251-1260
OBJECTIVES: The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI). BACKGROUND: Glycoprotein IIb/IIIa inhibitors enhance thrombolysis. The role of combination therapy in clinical practice remains to be established. METHODS: Patients (n = 438) with STEMI <6 h were enrolled. In dose-finding, 189 patients were randomized to different combinations of double-bolus eptifibatide and reduced-dose TNK. In dose-confirmation, 249 patients were randomized 1:1 to eptifibatide 180 microg/kg bolus, 2 microg/kg/min infusion, and 180 microg/kg bolus 10 min later (180/2/180) plus half-dose TNK (0.27 mg/kg) or standard-dose (0.53 mg/kg) TNK monotherapy. All patients received aspirin and unfractionated heparin (60 U/kg bolus; infusion 7 U/kg/h [combination], 12 U/kg/h [monotherapy]). The primary end point was Thrombolysis In Myocardial Infarction (TIMI) grade 3 epicardial flow at 60 min. RESULTS: In dose-finding, TIMI grade 3 flow rates were similar across groups (64% to 68%). Arterial patency was highest for eptifibatide 180/2/180 plus half-dose TNK (96%, p = 0.02 vs. eptifibatide 180/2/90 plus half-dose TNK). In dose-confirmation, this combination, compared with TNK monotherapy, tended to achieve more TIMI 3 flow (59% vs. 49%, p = 0.15), arterial patency (85% vs. 77%, p = 0.17), and ST-segment resolution (median 71% vs. 61%, p = 0.08) but was associated with more major hemorrhage (7.6% vs. 2.5%, p = 0.14) and transfusions (13.4% vs. 4.2%, p = 0.02). Intracranial hemorrhage occurred in 1.0%, 0.6%, and 1.7% of patients treated with any combination, eptifibatide 180/2/180 and half-dose TNK, and TNK monotherapy, respectively. CONCLUSIONS: Double-bolus eptifibatide (180/2/180) plus half-dose TNK tended to improve angiographic flow and ST-segment resolution compared with TNK monotherapy but was associated with more transfusions and non-cerebral bleeding. Further study is needed before this combination can be recommended for general use. 相似文献